Black Women and Endometrial Cancer: Key Information
Understanding Endometrial cancer Disparities for Black Women
Table of Contents
Endometrial cancer, a disease affecting the uterus, presents a stark and concerning health disparity for Black women. While it is often treatable when detected early, a complex interplay of factors leads to Black women facing higher rates of aggressive subtypes, later-stage diagnoses, and significantly worse survival outcomes compared to white women.
The Growing Threat of Non-Endometrioid Cancers
While endometrial cancer overall is a concern, research highlights a troubling trend: non-endometrioid subtypes are becoming more prevalent across all women. Though, this aggressive shift disproportionately impacts Black women. Amanda Onyewuenyi, MD, MPH, a gynecologist with Reiter, Hill & Johnson of Advantia in Washington, D.C., notes that black women are diagnosed with these more aggressive subtypes twice as often as women in other racial groups. This increased prevalence of aggressive cancer types is a critical factor contributing to the poorer outcomes observed.
Black Women Are Often Diagnosed at an Advanced Stage
The curability of endometrial cancer is heavily dependent on early detection. Unfortunately, for Black women, this crucial window is frequently missed, leading to diagnoses at more advanced stages. Ritu Salani, MD, a board-certified gynecologic oncologist at UCLA Health in Los Angeles, explains that by the time endometrial cancer is diagnosed in many Black women, it has already progressed to Stage 4.
Stage 4 endometrial cancer signifies that the disease has spread to other organs.While treatment at this advanced stage can still manage the condition, minimize symptoms, and prevent further spread, it is rarely curative. Women with advanced endometrial cancer may experience symptoms such as pelvic discomfort, unexplained weight loss, a feeling of fullness in the pelvis, and vaginal bleeding.
Black Women Face Much Higher Death Rates From Endometrial Cancer
the consequences of later-stage diagnoses and more aggressive cancer subtypes are tragically reflected in survival rates. Nationally, approximately 81 percent of women with endometrial cancer live at least five years after diagnosis. This figure is slightly higher for white women, at 84 percent. However, for Black women, this survival rate drops significantly to just 63 percent.This disparity means that a Black woman diagnosed with endometrial cancer is considerably more likely to die from the disease than a white woman. Tomeka roberts, MD, a board-certified gynecologist in Birmingham, Alabama, emphasizes that Black women are about twice as likely to die from endometrial cancer than white women. This stark difference makes it one of the most pronounced racial disparities seen in any cancer type globally, underscoring the urgent need for targeted research, improved screening, and equitable access to care.